Popular hearing aid company behind pharmaceutical treatment of deafness gets listed – plans to raise almost half a billion in DKK
US Decibel Therapeutics gets listed in the US, where the company – which has raised million-dollar figures on four prior occasions – plans to fetch USD 75m for the development of a pharmaceutical treatment for reduced hearing.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
US biotech firm Decibel Therapeutics has declared that it plans to become the world's leading firm for the pharmaceutical treatment of hearing loss. The firm is now getting listed on the Nasdaq stock exchange in New York, where it plans to raise USD 75m, according to a registration statement which the company has sent to the US stock authority the Securities and Exchange Commission (SEC).
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
.jpg)
